However, low expression levels of CD18 may also be due to a specific variant found in CLL patients harboring a mutation that results in a single amino acid residue change from glutamate to lysine (E630K), which is predicted to alter the protein function [170]. This evidence concerns the gene ITGB2 and B-cell chronic lymphocytic leukemia.